The invention relates to a method for establishing the sensitivity of tumors towards capecitabine, if applicable in combination with Docetaxel or Paclitaxel or the humanized antibody Herceptin, or COX-2 inhibitors or angiogenesis inhibitors and test kit.Fields of application of the invention are the pharmaceutical industry and bio-sciences: biology, biochemistry, biotechnology, medicine and medicinal technology.